Jiyeon Kweon

Title: Jiyeon Kweon: Innovator in Hemophilia Research

Introduction

Jiyeon Kweon is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of genetic research, particularly in the treatment of hemophilia. With a total of 3 patents, her work focuses on innovative methods for correcting genetic mutations associated with this condition.

Latest Patents

Among her latest patents is the invention titled "RNA guided endonuclease targeting blood coagulation factor VIII intron 1 inversion gene and composition for treating hemophilia comprising same." This invention provides a method for inducing an inversion of the normal blood coagulation factor VIII (F8) gene. It also includes a method for correcting an inversion of the F8 gene that has already occurred. The invention is particularly relevant for Hemophilia A patients, as it enables the construction of induced pluripotent stem cells with corrected inversions. This method effectively reproduces the inversion of intron 1 and intron 22 of the F8 gene, which is responsible for the majority of severe hemophilia A cases. The invention serves as a valuable research tool for studying the development mechanism of hemophilia A and for screening therapeutic agents.

Another notable patent is "Talen targeting blood coagulation factor VIII intron 1 inversion gene and composition for treating hemophilia comprising same." Similar to her previous work, this invention also focuses on correcting the inversion of the F8 gene. The inversion-corrected induced pluripotent stem cells constructed using this method enable efficient treatment for hemophilia A by restoring the genotype to a wild type-like state.

Career Highlights

Jiyeon Kweon is affiliated with Yonsei University, where she conducts her research and develops her innovative solutions. Her work has garnered attention in the scientific community for its potential to revolutionize the treatment of hemophilia.

Collaborations

She collaborates with esteemed colleagues, including Dong Wook Kim and Jin Soo Kim, to further advance her research and innovations in the field.

Conclusion

Jiyeon Kweon's contributions to hemophilia research through her innovative patents highlight her role as a leading inventor in genetic therapies. Her work not only addresses critical medical challenges but also paves the way for future advancements in the treatment of genetic disorders.